You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, February 2015
|
DOI | 10.1186/s13023-015-0228-7 |
Pubmed ID | |
Authors |
Linda Rossi-Semerano, Bruno Fautrel, Daniel Wendling, Eric Hachulla, Caroline Galeotti, Luca Semerano, Isabelle Touitou, Isabelle Koné-Paut, the MAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on the behalf of CRI (Club Rhumatisme et Inflammation) |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
Germany | 1 | <1% |
Canada | 1 | <1% |
Unknown | 124 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 24 | 19% |
Researcher | 18 | 14% |
Student > Ph. D. Student | 15 | 12% |
Other | 13 | 10% |
Student > Master | 12 | 9% |
Other | 28 | 22% |
Unknown | 18 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 40% |
Pharmacology, Toxicology and Pharmaceutical Science | 13 | 10% |
Agricultural and Biological Sciences | 11 | 9% |
Biochemistry, Genetics and Molecular Biology | 8 | 6% |
Immunology and Microbiology | 6 | 5% |
Other | 15 | 12% |
Unknown | 24 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2015.
All research outputs
#19,945,185
of 25,374,917 outputs
Outputs from Orphanet Journal of Rare Diseases
#2,289
of 3,105 outputs
Outputs of similar age
#272,049
of 385,282 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#28
of 37 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,282 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.